Clinical trial
Prevalence of Low Response to Clopidogrel in Patients After Acute Ischemic Stroke. The Bochumer CRISP Study
NCT01846572 is registered in ClinicalTrials.gov with Ruhr University of Bochum as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prevalence of Low Response to Clopidogrel in Patients After Acute Ischemic Stroke. The Bochumer CRISP Study
- Lead sponsor
- Ruhr University of Bochum
- Phase
- Observational
- Overall status
- Completed
- Start date
- July 31, 2010
- Completion date
- December 31, 2012
- Enrollment
- 159 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.